BEIJING, April 24, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that Dehaier becomes the exclusive after-sales service agent of Heyer Medical AG ("Heyer") for its anesthesia machine and ultrasound nebulizer products.
Under the agreement, Dehaier will be the exclusive technical service provider in mainland China for all Heyer products sold in the country, including product installation, user training, maintenance and product upgrading. The agreement also extends Dehaier's exclusive distribution authorization for Heyer anesthesia machines and ultrasound nebulizers for two years. Mr. Ping Chen, Chairman and CEO of Dehaier, noted, "We are pleased to deepen our cooperation with Heyer and look forward to sharing Heyer's high-quality medical products in China."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn
About Heyer Medical
Founded in 1883, Heyer became an innovator in inhalation technology for the treatment of respiratory tract diseases. Today HEYER is an internationally acknowledged specialist in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment. The products are used all over the world, particularly in the medical field, in clinics and practices in Europe and Asia as well as in the Middle East, South America and the USA. Their inhalation equipment is also increasingly used in wellness applications and for treatment and care at home.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the implementation of the Heyer agreement. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Dehaier Medical Systems Limited
Dehaier Medical Systems Limited